Methylenedioxymethamphetamine (MDMA)-induced toxic leukoencephalopathy: A case report

Haitham Salem, Travis Barton, Taha Ali, Ashley Anderson, Antonio L. Teixeira

Research output: Contribution to journalArticlepeer-review

Abstract

In recent years, ecstasy has become a very popular recreational drug. To date, very little data is available regarding its toxic side effects. Specifically, reports relating ecstasy use to the clinical diagnosis of leukoencephalopathy are quite rare. In this report, we present an interesting case of a 33-year-old female with a recent history of ecstasy abuse who presented with delirium and cognitive impairment. In addition, we review published case reports that explore the connection between MDMA and leukoencephalopathy.

Original languageEnglish (US)
Pages (from-to)215-219
Number of pages5
JournalPsychiatry and Clinical Psychopharmacology
Volume28
Issue number2
DOIs
StatePublished - 2018
Externally publishedYes

Keywords

  • Brain injury
  • Delirium
  • Leukoencephalopathy
  • MDMA
  • Neuropsychiatry

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Methylenedioxymethamphetamine (MDMA)-induced toxic leukoencephalopathy: A case report'. Together they form a unique fingerprint.

Cite this